BioAdaptivesBDPT -29.82% FCF Margin % is -1,416.67% as of Mar. 2026. The stock has 5 warning signs investors should review. Among 1,954 Consumer Packaged Goods companies, BioAdaptives ranks worse than 99.69% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BioAdaptives's Free Cash Flow for the
three
months ended in Mar. 2026 was $-0.09 Mil. BioAdaptives's Revenue for the
three
months ended in Mar. 2026 was $0.01 Mil. Therefore, BioAdaptives's FCF Margin % for the quarter that ended in Mar. 2026 was -1,416.67%.
The historical rank and industry rank for BioAdaptives's FCF Margin % or its related term are showing as below:
BDPT'
s FCF Margin % Range Over the Past 10 Years
Min: -2966.67 Med: -1335.29 Max: -668.75
Current: -2095.83
During the past 11 years, the highest FCF Margin % of BioAdaptives was -668.75%. The lowest was -2966.67%. And the median was -1335.29%.
BDPT's FCF Margin % is ranked worse than 99.69% of 1954
companies
in the Consumer Packaged Goods industry
Industry Median: 2.155
vs BDPT: -2095.83
BioAdaptives FCF Margin % Related Terms
BioAdaptives FCF Margin % Historical Data
* Premium members only.
The historical data trend for BioAdaptives's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, BioAdaptives's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioAdaptives FCF Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, BioAdaptives's FCF Margin % distribution charts can be found below:
* The bar in red indicates where BioAdaptives's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioAdaptives (BDPT) has a FCF Margin % of -1,416.67% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on BioAdaptives and its competitors. According to the industry distribution chart, BioAdaptives ranks #1948 out of 1954 companies in the Consumer Packaged Goods industry, placing it in the top 99.7%.
Is BioAdaptives' FCF Margin % too high?
BioAdaptives' current FCF Margin % is -1,416.67%. Based on the distribution chart, BioAdaptives ranks #1948 out of 1954 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does BioAdaptives' FCF Margin % compare to NBND and BSFC?
According to the Consumer Packaged Goods industry distribution chart, BioAdaptives ranks #1948 out of 1954 companies for FCF Margin %. This places BioAdaptives in the lower half of its industry. The industry median FCF Margin % is 2.16. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Consumer Packaged Goods company?
The median FCF Margin % among Consumer Packaged Goods companies is 2.16, based on 1,954 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on BioAdaptives and its competitors. For the Consumer Packaged Goods industry, the median FCF Margin % is 2.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioAdaptives's current FCF Margin % is -1,416.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioAdaptives stock overvalued right now?
BioAdaptives (BDPT) has a current FCF Margin % of -1,416.67%. The current FCF Margin % is -1,416.67%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For BioAdaptives (BDPT), the current FCF Margin % is -1,416.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BioAdaptives Inc is engaged in investigating, marketing, and distributing natural plant, algal, and cyanobacteria-based products and medical devices that enhance health and wellness for humans and animals, with a focus on nootropics, anti-aging, weight control, relaxation, pain relief, and anti-viral properties. The company's current products in development include dietary supplements utilizing natural ingredients and proprietary methods to optimize the availability of nutrients in foods and beverages. The human products are designed to aid in cognitive health, regenerative stem cell activation, and healthy weight loss. The company's products include MyndMed, Zeranovia, and Wynovia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDPT has been successfully added to your 